SG Americas Securities LLC boosted its stake in shares of PAREXEL International Corporation (NASDAQ:PRXL) by 841.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,493 shares of the medical research company’s stock after buying an additional 79,986 shares during the period. SG Americas Securities LLC owned 0.18% of PAREXEL International Corporation worth $7,778,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio raised its position in PAREXEL International Corporation by 4.5% in the first quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock valued at $108,000 after buying an additional 73 shares in the last quarter. Meadow Creek Investment Management LLC raised its position in PAREXEL International Corporation by 7.1% in the first quarter. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company’s stock valued at $125,000 after buying an additional 132 shares in the last quarter. Invictus RG purchased a new position in PAREXEL International Corporation during the first quarter valued at approximately $158,000. Glen Harbor Capital Management LLC raised its position in PAREXEL International Corporation by 7.1% in the first quarter. Glen Harbor Capital Management LLC now owns 2,520 shares of the medical research company’s stock valued at $159,000 after buying an additional 168 shares in the last quarter. Finally, Elkfork Partners LLC raised its position in PAREXEL International Corporation by 7.1% in the first quarter. Elkfork Partners LLC now owns 3,060 shares of the medical research company’s stock valued at $193,000 after buying an additional 204 shares in the last quarter. 91.58% of the stock is currently owned by hedge funds and other institutional investors.

Shares of PAREXEL International Corporation (PRXL) opened at 87.76 on Thursday. The company has a market capitalization of $4.45 billion, a price-to-earnings ratio of 38.58 and a beta of 0.79. PAREXEL International Corporation has a one year low of $51.16 and a one year high of $87.86. The company’s 50 day moving average is $87.39 and its 200 day moving average is $74.38.

COPYRIGHT VIOLATION WARNING: “PAREXEL International Corporation (PRXL) Position Increased by SG Americas Securities LLC” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/17/parexel-international-corporation-prxl-position-increased-by-sg-americas-securities-llc.html.

Several equities analysts have commented on the stock. Zacks Investment Research lowered shares of PAREXEL International Corporation from a “buy” rating to a “hold” rating in a report on Thursday. BidaskClub lowered shares of PAREXEL International Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Raymond James Financial, Inc. raised shares of PAREXEL International Corporation from an “underperform” rating to a “mkt perform” rating in a report on Tuesday, June 20th. Jefferies Group LLC reissued a “hold” rating and issued a $88.10 target price on shares of PAREXEL International Corporation in a report on Wednesday, June 21st. Finally, Mizuho raised their target price on shares of PAREXEL International Corporation from $66.00 to $75.00 and gave the company a “buy” rating in a report on Tuesday, May 30th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. PAREXEL International Corporation presently has an average rating of “Hold” and a consensus target price of $75.93.

PAREXEL International Corporation Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Corporation (NASDAQ:PRXL).

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Receive News & Stock Ratings for PAREXEL International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Corporation and related stocks with our FREE daily email newsletter.